Metraipolis › archive › dc_85cff4e45be6

Monocyte-to-lymphocyte ratio as a predictor of outcomes in patients with hepatocellular carcinoma — Europe PMC PMID:42180081

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42180081
DOI: 10.3389/fonc.2026.1738719
License (as archived): solo-consultazione
Archived: 2026-11-02T14:56:57.250Z
SHA-256 of the archived text: 65ddc82542ed6a014f20229686ac9444740508f6cc58dac51a1ccc502ed59454
Stable URL of this page: https://metraipolis.com/documento/dc_85cff4e45be6

How to cite

Monocyte-to-lymphocyte ratio as a predictor of outcomes in patients with hepatocellular carcinoma — Europe PMC PMID:42180081 — Europe PMC (en), https://europepmc.org/article/MED/42180081 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_85cff4e45be6 (Metraipolis archive dc_85cff4e45be6, sha256 65ddc82542ed6a014f20229686ac9444740508f6cc58dac51a1ccc502ed59454)

BibTeX

@misc{dc85cff4e45be6,
  title = {Monocyte-to-lymphocyte ratio as a predictor of outcomes in patients with hepatocellular carcinoma — Europe PMC PMID:42180081},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42180081},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_85cff4e45be6; sha256 65ddc82542ed6a014f20229686ac9444740508f6cc58dac51a1ccc502ed59454},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42180081. Agents can read the archived copy with the MCP tool read_document.